Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ERBB3 overexpression
i
Other names:
ERBB3, HER3, LCCS2, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2065
Related biomarkers:
Expression
Mutation
CNA
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ERBB3 overexpression
Colorectal Cancer
ERBB3 overexpression
Colorectal Cancer
panitumumab
Sensitive: B - Late Trials
panitumumab
Sensitive
:
B
panitumumab
Sensitive: B - Late Trials
panitumumab
Sensitive
:
B
ERBB3 overexpression
Breast Cancer
ERBB3 overexpression
Breast Cancer
U3-1402
Sensitive: C3 – Early Trials
U3-1402
Sensitive
:
C3
U3-1402
Sensitive: C3 – Early Trials
U3-1402
Sensitive
:
C3
ERBB3 overexpression
Triple Negative Breast Cancer
ERBB3 overexpression
Triple Negative Breast Cancer
gefitinib
Sensitive: C3 – Early Trials
gefitinib
Sensitive
:
C3
gefitinib
Sensitive: C3 – Early Trials
gefitinib
Sensitive
:
C3
ERBB3 overexpression
Triple Negative Breast Cancer
ERBB3 overexpression
Triple Negative Breast Cancer
HDAC inhibitor + AKT2 inhibitor
Sensitive: C3 – Early Trials
HDAC inhibitor + AKT2 inhibitor
Sensitive
:
C3
HDAC inhibitor + AKT2 inhibitor
Sensitive: C3 – Early Trials
HDAC inhibitor + AKT2 inhibitor
Sensitive
:
C3
ERBB3 overexpression
Triple Negative Breast Cancer
ERBB3 overexpression
Triple Negative Breast Cancer
HDAC inhibitor + AKT1 inhibitor
Sensitive: C3 – Early Trials
HDAC inhibitor + AKT1 inhibitor
Sensitive
:
C3
HDAC inhibitor + AKT1 inhibitor
Sensitive: C3 – Early Trials
HDAC inhibitor + AKT1 inhibitor
Sensitive
:
C3
ERBB3 overexpression
Triple Negative Breast Cancer
ERBB3 overexpression
Triple Negative Breast Cancer
romidepsin
Sensitive: C3 – Early Trials
romidepsin
Sensitive
:
C3
romidepsin
Sensitive: C3 – Early Trials
romidepsin
Sensitive
:
C3
ERBB3 overexpression
Triple Negative Breast Cancer
ERBB3 overexpression
Triple Negative Breast Cancer
panobinostat
Sensitive: C3 – Early Trials
panobinostat
Sensitive
:
C3
panobinostat
Sensitive: C3 – Early Trials
panobinostat
Sensitive
:
C3
ERBB3 overexpression
Colorectal Cancer
ERBB3 overexpression
Colorectal Cancer
U3-1402
Sensitive: D – Preclinical
U3-1402
Sensitive
:
D
U3-1402
Sensitive: D – Preclinical
U3-1402
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login